Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2024-08-30 00:00:00 ET · period of report 2024-08-28 · accession 0001213900-24-074514 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-30 | 2024-08-28 | TARA | Shefferman Jesse | CEO, Pres, Dir | G - Gift | $0.00 | -8,563 | 935.5K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-28 | G | D | 5,263 | $0.00 | 938,801 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-28 | G | D | 3,300 | $0.00 | 935,501 | D | — | — |